Seed Round

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

A high-level visit to General Atomics signals a major U.S. push for fusion energy, blending private innovation with public funding to win a global race.

A new partnership combines local infrastructure with global expertise, aiming to streamline development for startups and solidify Singapore's biotech leadership.

A new company is selling franchises to doctors and pharmacists, promising to cut out insurers and restore local care. But can this bold model survive the system?

Five new clinical trials in Chicago repurpose existing drugs for PTSD, cancer, and more, offering a faster, cheaper path to treating unsolved diseases.

Brands are disappearing from new AI search engines. A new discipline called 'Machine Relations' aims to solve this 'AI invisibility' crisis.

Evaline Tsai's promotion at Gigascale Capital highlights a new VC playbook where deep scientific expertise is crucial for funding our physical economy's future.

A Swiss biotech's novel antibiotic has entered human trials with new funding, offering a fresh hope against the world's most dangerous superbugs.

Ann Arbor startup Adrenaline Interactive lands a $1M prize to revolutionize in-game ads, signaling Michigan's push to become a tech innovation hub.

A small environmental firm unveils a plan to upend global markets with a fraud-proof 'Physical Truth Infrastructure.' But can it deliver on its promises?

Miami startup Petwealth emerges from stealth with at-home PCR tests and key partnerships, aiming to revolutionize the $200B pet health industry.

As AlphaPepe prepares to launch its AI-powered crypto exchange amidst a bullish market, a closer look at its security audit reveals significant contradictions.

With a $5M private placement, Ubercrete is one step closer to a public listing and revolutionizing the construction industry with its advanced concrete tech.

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.

With its lead drug for a rare pediatric liver disease entering late-stage trials, NorthSea Therapeutics adds a veteran drug developer to its board.

New research shows parents welcome corporate sponsors in schools to fill funding gaps, creating a powerful new marketing channel built on community trust.

A Georgia firm's painless patch technology earns top honors, promising to revolutionize medicine delivery and solve critical global health challenges.

A new protocol aims to tokenize AI hardware, bridging a $2.5T finance gap and creating a new asset class for the digital age. Here's how it works.

Fueled by a $250K grant from Allen Family Philanthropies, a new pilot aims to tackle Seattle's infamous social isolation with a structured national plan.

After a standout debut at CES 2026, the emotionally intelligent robot OlloNi is heading to Kickstarter. Can it turn industry buzz into a new reality?